-
1
-
-
0021864792
-
Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial
-
Amery A., Birkenhäger W., Brixko P.et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet. i:1985;1351-1354.
-
(1985)
Lancet
, vol.1
, pp. 1351-1354
-
-
Amery, A.1
Birkenhäger, W.2
Brixko, P.3
-
2
-
-
0022469583
-
Randomised trial of treatment of hypertension in elderly patients in primary care.
-
Coope J., Warrender T.S. Randomised trial of treatment of hypertension in elderly patients in primary care. BMJ. 293:1986;1145-1151.
-
(1986)
BMJ
, vol.293
, pp. 1145-1151
-
-
Coope, J.1
Warrender, T.S.2
-
3
-
-
0025831464
-
Prevention of stroke by hypertensive drug therapy in older persons with isolated systolic hypertension: Final results of the systolic hypertension in the elderly program
-
Prevention of stroke by hypertensive drug therapy in older persons with isolated systolic hypertension: final results of the systolic hypertension in the elderly program. JAMA. 265:1991;3255-3264.
-
(1991)
JAMA
, vol.265
, pp. 3255-3264
-
-
-
4
-
-
0025942936
-
Morbidity and mortality in the Swedish trial in Old Patients with Hypertension (STOP-Hypertension)
-
Dahlöf B., Lindholm L.H., Hansson L.et al. Morbidity and mortality in the Swedish trial in Old Patients with Hypertension (STOP-Hypertension). Lancet. 338:1991;1281-1285.
-
(1991)
Lancet
, vol.338
, pp. 1281-1285
-
-
Dahlöf, B.1
Lindholm, L.H.2
Hansson, L.3
-
5
-
-
0026512315
-
Medical Research Council trial of treatment of hypertension in older adults: Principal results
-
Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ. 304:1992;405-412.
-
(1992)
BMJ
, vol.304
, pp. 405-412
-
-
-
6
-
-
0343487983
-
Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
-
Staessen J.A., Fagard R., Thijs L. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet. 350:1997;757-764.
-
(1997)
Lancet
, vol.350
, pp. 757-764
-
-
Staessen, J.A.1
Fagard, R.2
Thijs, L.3
-
7
-
-
0031769003
-
Comparison of active treatment and placebo for older Chinese patients with isolated systolic hypertension
-
Liu L., Wang J.G., Gong L., Liu G., Staessen J.A. Comparison of active treatment and placebo for older Chinese patients with isolated systolic hypertension. J Hypertens. 16:1998;1823-1829.
-
(1998)
J Hypertens
, vol.16
, pp. 1823-1829
-
-
Liu, L.1
Wang, J.G.2
Gong, L.3
Liu, G.4
Staessen, J.A.5
-
8
-
-
0027487919
-
STOP-Hypertension-2: A prospective intervention trial of "newer" versus "older" treatment alternatives in old patients with hypertension
-
Dahlöf B., Hansson L., Lindholm L.H.et al. STOP-Hypertension-2: a prospective intervention trial of "newer" versus "older" treatment alternatives in old patients with hypertension. Blood Press. 2:1993;136-141.
-
(1993)
Blood Press
, vol.2
, pp. 136-141
-
-
Dahlöf, B.1
Hansson, L.2
Lindholm, L.H.3
-
9
-
-
0029778444
-
The Swedish trial in Old Patients with Hypertension (STOP-Hypertension-2): A progress report
-
Lindholm L.H., Hansson L., Dahlöf B. The Swedish trial in Old Patients with Hypertension (STOP-Hypertension-2): a progress report. Blood Press. 5:1996;300-304.
-
(1996)
Blood Press
, vol.5
, pp. 300-304
-
-
Lindholm, L.H.1
Hansson, L.2
Dahlöf, B.3
-
10
-
-
0026911107
-
Prospective Randomised Open Blinded End-point (PROBE) study: A novel design for intervention trials
-
Hansson L., Hedner T., Dahlöf B. Prospective Randomised Open Blinded End-point (PROBE) study: a novel design for intervention trials. Blood Press. 1:1992;113-119.
-
(1992)
Blood Press
, vol.1
, pp. 113-119
-
-
Hansson, L.1
Hedner, T.2
Dahlöf, B.3
-
11
-
-
0033034404
-
Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension
-
Hansson L., Lindholm L.H., Niskanen L. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension. Lancet. 353:1999;611-616.
-
(1999)
Lancet
, vol.353
, pp. 611-616
-
-
Hansson, L.1
Lindholm, L.H.2
Niskanen, L.3
-
12
-
-
0029830418
-
11 collaborating centres in the Shanghai area: Shanghai trial of nifedipine in the elderly (STONE)
-
Gong L., Zhang W., Zhu Y.et al. 11 collaborating centres in the Shanghai area: Shanghai trial of nifedipine in the elderly (STONE). J Hypertens. 14:1996;1237-1245.
-
(1996)
J Hypertens
, vol.14
, pp. 1237-1245
-
-
Gong, L.1
Zhang, W.2
Zhu, Y.3
-
13
-
-
0000362047
-
Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding
-
Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding. J Hypertens. 15:1997;105-115.
-
(1997)
J Hypertens
, vol.15
, pp. 105-115
-
-
-
14
-
-
0033003220
-
Calcium antagonists and safety: The turning of the tide
-
van Zwieten P.A., Hansson L. Calcium antagonists and safety: the turning of the tide. Blood Press. 8:1999;5-8.
-
(1999)
Blood Press
, vol.8
, pp. 5-8
-
-
Van Zwieten, P.A.1
Hansson, L.2
-
15
-
-
0032513878
-
Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
-
Hansson L., Zanchetti A., Carruthers S.G.et al. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet. 351:1998;1755-1762.
-
(1998)
Lancet
, vol.351
, pp. 1755-1762
-
-
Hansson, L.1
Zanchetti, A.2
Carruthers, S.G.3
|